Storage pool-deficient (SPD) platelets, which have decreased amounts of dense-granule and/or a-granule constituents, contain normal amounts of lysosomal acid hydrolases, but in some cases exhibit impaired secretion of these enzymes. We examined this impaired secretion response in SPD patients with varying extents of granule deficiencies, and determined the effects of added dense-granule constituents. Acid hydrolase secretion was impaired in patients with severe dense-granule deficiencies, but not in patients with lesser dense-granule deficiencies, including those with a-granule deficiencies as well. When dense-granule constituents (ADP, ATP, serotonin, Ca+2, pyrophosphate) were added to gel-filtered platelets, ADP, but none of the other constituents, completely corrected the impairment of thrombin and A23187-induced secretion in SPD platelets. The concentration of ADP required to normalize thrombin-induced secretion varied markedly, from 0.01 to 10 ,pM, among the individual patients. Fixation of platelets with formaldehyde before centrifugation did not prevent the enhancement of secretion by ADP. Excess ATP, which acts as a specific antagonist of ADP-mediated responses, completely blocked this enhancement of secretion in SPD platelets by ADP, and partially inhibited acid hydrolase secretion induced by low, but not high, concentrations of thrombin in normal platelets as well. Treatment of normal platelets with acetylsalicylic acid in vivo, but not in vitro, produced an impairment of acid hydrolase secretion similar in extent to that in SPD platelets, but which could not be completely corrected by added ADP. One possible explanation of these results is that the impairment of acid hydrolase secretion may be secondary to the dense-granule deficiency in SPD platelets, and that secreted ADP may potentiate the lysosomal secretion response in normal platelets as well.
Introduction
The secretion response in human blood platelets encompasses the extrusion of the contents of at least three different types of A preliminary report of this work was presented at the 7th National Conference on Thrombosis and Haemostasis of the American Heart Association, November 1986 and was published in abstract form (1986 [PPj] are secreted from the dense granules, proteins such as fibrinogen, von Willebrand factor, factor V, fl-thromboglobulin, platelet factor 4, and platelet-derived growth factor are secreted from a-granules, and a variety of acid hydrolytic enzymes are secreted from the lysosomal granules (1) . Both quantitative and qualitative differences are found in the patterns of secretion from these granules, primarily in those of lysosomal vs. dense-granule and a-granule secretion. Thus, only 30-60% of the lysosomal enzymes are secreted in response to maximal stimulation, compared with 80-100% of the dense-granule and agranule contents (1) . In addition, only dense-granule and a-granule secretion, and not lysosomal secretion, are induced by weak agonists such as ADP or epinephrine (2) , and thrombin-induced acid hydrolase secretion, in marked contrast to dense-granule secretion, requires continuous occupancy ofthe thrombin receptor (3) . The dose dependency (4, 5) , kinetics (6) , and energy requirements (6, 7) also differ among these three secretory processes when induced by thrombin. These differences in secretion patterns suggest that differences exist in the mechanisms of secretion for each granule, in particular for lysosomal vs. dense-granule and a-granule secretion.
In platelets from patients with storage pool deficiency (SPD), the contents of one or more of these secretory granules are reduced or absent (8) . We have characterized the types of deficiencies found in SPD (8) , which include deficiencies of dense granules (6-SPD), as seen in patients with the Hermansky-Pudlak syndrome (9) , the Chediak-Higashi syndrome (10) (11) (12) , and patients without oculocutaneous albinism (8, 13) ; deficiencies of both dense granules and a-granules (ab-SPD) (8) and selective deficiencies of a-granules (a-SPD), as in the gray platelet syndrome (14) . The granule deficiencies in SPD do not appear to include the lysosomes, however, since the platelet contents of acid hydrolases were found to be normal in all SPD patients in our studies (4, 8) as well as in patients with Chediak-Higashi syndrome ( 11) and gray platelet syndrome (14) .
We found in previous studies (4) that, despite their normal content of these enzymes, platelets from most SPD patients exhibited impaired acid hydrolase secretion in response to low, but not high concentrations of thrombin. A similar abnormality in acid-hydrolase secretion, but not in platelet content, has also been described in the platelets of patients with attentiondeficit disorder (hyperkinesis) (15) . The current studies were undertaken to determine the relationship of this secretion defect to the granule deficiencies present in SPD platelets. Our findings that ADP specifically corrected this impairment of acid hydrolase secretion suggest that this defect is secondary to the dense-granule deficiency in SPD platelets. We have also obtained evidence that ADP potentiates acid hydrolase secretion in normal platelets as well.
Methods
Collection ofblood, preparation ofplatelet-rich plasma (PRP) and gelfiltered platelets (GFP). After obtaining informed consent from SPD patients and normal subjects, blood was collected by venipuncture into 0.1 vol of 0.109 M sodium citrate dihydrate. PRP was prepared by centrifugation of citrated whole blood at 1,500 g for 3 min at room temperature and was gel-filtered on Sepharose 2B as described previously (16) . The platelets were eluted into Ca-and Mg-free Tyrode's buffer, pH 7.4, containing 1 g/liter dextrose and 2 g/liter lyophilized human serum albumin (Sigma Chemical Co., St. Louis, MO). In some studies, Ca-and Mg-free Tyrode's without phosphate and containing 0.2 mM Sr"2 was used as the elution fluid. The extents of acid hydrolase secretion were not affected by these alterations.
Thrombin and A23187-induced acid hydrolase secretion. Aliquots ofGFP were preincubated with 1.4 mM EDTA at 370C for 3 min prior to addition of thrombin. In some studies, dense-granule constituents (ATP, ADP, 5HT, Ca"2, PP1 or epinephrine) were added to GFP just before or simultaneously with addition of thrombin. Incubation with thrombin (0.04, 0.30, or 5.0 U/ml final concentration [f.c.]) was for an additional 3 or 10 min at 37°C without stirring, after which the samples were transferred to an ice bath. The samples were then centrifuged at 17,500 g for 10 min at 4°C. Aliquots of the supernates were extracted by addition of 1.8% Triton X-100 (1:8 vol/vol) and frozen at -45°C until assayed. Control samples were treated with 0.15 M NaCI instead of thrombin, and the acid hydrolase activities in these supernates were subtracted from the activities of the thrombin-treated samples. Total platelet acid hydrolase activities were measured in an aliquot of GFP incubated as above with 0.15 M saline and then extracted directly without centrifugation.
For initial studies of the acid hydrolase activities secreted by A23 187, aliquots of GFP in Ca-and Mg-free Tyrode's without phosphate and with 0.2 mM Sr2" were treated with DMSO, 4 or 12 AM (f.c.)
A23 187, added in 0.001 vol. Samples were incubated for 3 min at 37°C without stirring, then transferred into tubes containing 0.05 vol 0.1 M EDTA, pH 7.4, in an ice bath, and centrifuged and extracted as described above. Subsequent studies were carried out in the presence of EDTA, as described above for the studies with thrombin.
In studies of the effects of formaldehyde fixation, the aliquots of GFP were split after incubation with thrombin or A23 187. One-half of the sample was removed and added to 0.05 vol 0. 135 M formaldehyde on ice, and the second halfofthe sample placed directly in the ice bath. To control for any effects of formaldehyde on the extraction or assay procedures, an equivalent amount of formaldehyde was added to onehalfofthe total (uncentrifuged) sample prior to extraction with Triton. Separate studies showed that the presence of formaldehyde had no effect on the acid hydrolase assay itself. (16) .
For studies of the effects of in vitro aspirin or salicylate incubation on thrombin-induced acid hydrolase secretion in normal subjects, platelets were incubated with 200MM acetylsalicylic acid (ASA) in 0.12 M NaHCO3, salicylic acid in NaHCO3, or 0.12 M NaHCO3 alone, for 10 min at 37°C, either in PRP prior to gel filtration or directly in GFP, and then treated with thrombin in the absence or presence of ADP.
Assay ofacid hydrolase activities. The activities of f-hexosaminidase, fl-galactosidase, and fl-glucuronidase were determined by spectrophotometric assay ofp-nitrophenol hydrolyzed from the substrates p-nitrophenyl-N-acetyl-j%-iglucosaminide, p-nitro-phenyl-3-D-galactopyranoside, and p-nitrophenyl-(3-D-glucuronide, respectively, according to previously described methods (4, 17) . For these studies, however, assay incubation times were increased to I h for fl-hexosaminidase, 3 h for fl-galactosidase, and 5 h for f-glucuronidase. In some studies, acid hydrolase activity was assayed by spectrofluorometry using the appropriate 4-methylumbelliferyl glycoside substrates (17) Patients. A total of 18 patients with various types of SPD were studied. Nine patients had 6-SPD associated with oculocutaneous albinism (Hermansky-Pudlak syndrome), while six patients had SPD not associated with albinism. Three patients (D.C., S.C., R.C.: mother, son, and daughter) (18) have been characterized as having partial deficiencies of a-granules and a-granule constituents in addition to densegranule deficiencies (8) . Most of these patients have been described in previous studies (8, 13, 18, 19) . All ofthe patients were not included in each of the various studies. Control subjects were hospital and laboratory personnel who denied ingestion of any medication for 7 d prior to study. In some studies, control subjects were studied before and 2 h after ingestion of 650 mg of ASA.
Statistical analyses. Statistical significance was determined by the Student's t test, or paired t test where applicable, with appropriate corrections for small sample size and for the possibility of nonequivalent variances in patient and control groups (20).
Results
Thrombin and A23187-induced acid hydrolase secretion. In accord with previous studies (4), the secretion of ,B-hexosaminidase, f3-galactosidase, and fl-glucuronidase was decreased in response to low (0.04 and 0.3 U/ml) concentrations of thrombin in SPD platelets ( Fig. 1 A) . Secretion of,B-hexosaminidase and f3-glucuronidase became normal in the SPD platelets at 5 U/ml thrombin, as also found previously (4), whereas fl-galactosidase secretion remained slightly (P < 0.025, one-tailed t test) decreased (Fig. 1 A) . Secretion of these three acid hydrolases was also decreased in SPD platelets, in response to both 4 and 12 MM A23187 ( Fig. 1 B) . Higher concentrations of A23 187 could not be studied because of the lytic effects of this agonist (19) .
Increasing the incubation time from 3 to 10 min did not increase the extents of secretion obtained in platelets from five SPD patients in response to 0.04 U/ml thrombin and 12 uM A23 187 (data not shown). Thus, the impaired secretion is not the result of delayed response.
These patterns of impaired acid hydrolase secretion were observed in platelets from most, but not all, SPD patients.
Impaired secretion occurred in patients previously character- and corrected for the activity in supernates of unstimulated (saline or DMSO-treated) GFP. Significance levels, for SPD vs. normal, are given as: NS, not significant; *P < 0.025; **P < 0.005; ***P < 0.001.
ized as having deficiencies of dense granules only (6-SPD) (8) , and was particularly evident in the b-SPD albino patients (Table I) . These patients exhibit the most severe dense-granule deficiencies, as indicated by a virtual absence of secreted ATP and ADP in response to 5 U/ml thrombin (19) . In contrast, little or no impairment of acid hydrolase secretion was ob- Effect of added (extracellular) dense-granule constituents on thrombin-induced acid hydrolase secretion. To examine this possible involvement of dense-granule substances in acid hydrolase secretion, the secretion of,-hexosaminidase induced by a lo* concentration (0.04 U/ml) ofthrombin was measured in normal and SPD platelets in the presence of added densegranule constituents (ATP, ADP, 5HT, Ca+2, and PPJ) at concentrations approximating those obtained extracellularly after maximal secretion in normal platelets. As shown in Fig. 2 , none of these dense-granule constituents had any effect on ,B-hexosaminidase secretion in normal platelets. However, ADP, but none ofthe other constituents, completely corrected the impaired secretion response seen in SPD platelets. When ADP was added together with the other dense-granule constituents, secretion was also significantly increased in the SPD platelets compared with the extent in the absence of these constituents (12.2±1.05 SE vs. 8.6±1.2, P < 0.025, paired t test), but remained slightly less than that obtained in normal platelets.
Since these studies were performed in the presence of 1.4 mM EDTA to eliminate any effects of platelet-platelet interactions on the secretion response, the effects of Ca+2 were therefore also examined in the absence of EDTA. The extent of fl-hexosaminidase secretion in SPD platelets was increased when 40 1AM Ca+2 was added in the absence of EDTA, but was also increased in the absence of EDTA without addition of Ca+2 (Table II) . However, similar increases were also seen in normal platelets under the same conditions. Thus, this enhancement of ,-hexosaminidase secretion by Ca+2 appears to represent a more general influence on the secretory response, (Fig. 4) . In these and some other studies (see below), ADP and ATP were both present at concentrations corresponding to the maximal amounts secreted from platelet dense granules (5 uM each). However, as for the thrombininduced response (Fig. 2) , subsequent studies showed that 
tion is expressed relative to the value obtained without addition of ADP or epinephrine, which in these studies was 7.5±0.6% (SE) (n = 5), and is given as mean±SE. The asterisks indicate significance levels of P < 0.05 relative to the no additions value, as assessed by a one-tailed paired t test. MM each) to GFP and treatment with A23187 was performed as for the thrombin studies described in Fig. 2 . The values are mean±SE extents of secretion in GFP from four SPD patients (darkened bars) and nine normal subjects (open bars). The correction of the secretion response in SPD platelets in the presence of ADP + ATP is due to ADP, since, in separate studies, ATP alone was found to have no effect on the secretion response.
ATP alone, at these concentrations, did not alter the extent of A23 187-induced secretion (data not shown). Thus the, correction of the impaired' secretion response seen in Fig. 4 is also attributed to the effects of added ADP.
Enhancement of secretion by ADP in formaldehyde-fixed SPD platelets. Platelet secretion can also be induced during centrifugation by close-cell contact mechanisms (23) ,. and these effects can be prevented by treatment with formaldehyde prior to centrifugation. (24) . To determine whether ADP might enhance acid hydrolase secretion via'effects on such mechanisms, secretion was measured in platelets treated with formaldehyde after stimulation with thrombin or A23187 but prior to centrifugation (Table III) . Formaldehyde treatment decreased the extents of secretion in both SPD and normal platelets, compared with the values obtained in the absence of formaldehyde (cf. Figs. 2 and 4) , indicating a contribution of clQse-cell contact mechanisms with both agonists. This decrease, and hence the relative contribution of these mechanisms, was greater for A23187 than for thrombin. However, both thrombin and A23187-induced acid hydrolase secretion were still completely corrected in the presence of ADP plus ATP when formaldehyde was added after stimulation. (As noted above, this correction is attributed specifically to ADP.) Thus, ADP acts directly on the agonist-induced stimulation occurring in suspension rather than on close-cell contact-mediated activation occurring during centrifugation. Concentration dependence of ADP enhancement of acid hydrolase secretion. The effects of varying concentrations of ADP, from 0.01 to 10 AM, on the acid hydrolase secretion response were studied in platelets from five SPD patients. As shown in Fig. 5 , the mean extent of fl-hexosaminidase secretion induced by 0.04 U/ml thrombin increased in a concentration-dependent manner over the range of ADP concentrations tested. At 0.5 MM ADP and above, the mean extent of secretion in the patients did not differ significantly from that in five normal subjects. Secretion was significantly increased in the SPD platelets even at 0.01 MM ADP, compared to the extent obtained in the absence of added ADP (P < 0.01, onetailed paired t test).
Among the individual patients, however, the sensitivity to ADP varied substantially. Fig. 6 shows the ADP dose-response data in the individual patients compared to the mean±2 SD ranges of the five normal subjects, In the patient with the 40 r highest level of secretion in the absence of ADP, addition of 0.01 uM ADP was sufficient to bring the extent of secretion into the normal range, whereas in three other patients with more severely impaired secretion responses, the extents of secretion did not reach the normal range until 10 ,M ADP was present. Thus, a considerable degree of heterogeneity in platelet sensitivity to the effects of ADP exists among the SPD patients. In none of the patients or normal subjects was ADP alone, in the absence of thrombin, capable of inducing (3- Table IV , the ability of 10 MAM ADP to increase'the throm- Additions of ATP and epinephrine were made as described in the legend to Table IV . Values are means±SE for four normal subjects.
* P < 0.05 relative to 500 MM ATP value, using a one-tailed paired t test.
bin-induced acid hydrolase secretion response in SPD platelets was completely abolished by 500 MAM ATP. Furthermore, in normal platelets, whereas ADP again had no effect on the secretion response, excess ATP partially inhibited secretion induced by 0.04 U/ml thrombin, but did not affect the response to a higher (1.0 U/ml) thrombin concentration. This inhibition by excess ATP could not be reversed by 10 AM ADP, but was reversed, in part, by addition of 5-10 ,M epinephrine (Table V) . However, as noted above relative to its effects in SPD platelets, this reversal of inhibition by epinephrine was seen only at micromolar levels, and did not occur at concentrations closer to physiological levels. Effects ofASA in vivo and in vitro on acid hydrolase secretion. The effects of exposure of normal platelets to ASA, both in vivo and in vitro, on thrombin-induced acid hydrolase secretion were compared with the impairment of this secretion response seen in SPD platelets. Incubation of normal platelets with ASA in vitro, either in PRP or GFP, had no effect on the extent of acid hydrolase secretion (Table VI) , in accord with previous observations (4) .
In marked contrast, exposure ofnormal platelets to ASA in vivo caused a significant decrease in the extent of fl-hexosaminidase secretion. A similar pattern of inhibition of acid hydrolasd secretion by ASA in vivo, but not in vitro, has also been observed in previous studies (27) . Addition of 10 uM ADP increased the extent of secretion after in vivo ASA treatment, but, unlike its effect on SPD platelets, failed to normalize the response completely. The differences seen in the effects of in vivo vs. in vitro ASA treatment on acid hydrolase secretion were not due to differences in inhibition of TxA2 formation. Under all conditions of incubation with ASA, TxA2 formation, measured by radioimmunoassay of TxB2, was inhibited by > 90%. In addition, incubation of platelets in vitro with 200 MAM salicylate did not alter the extent of fl-hexosaminidase secretion (data not shown).
Discussion
These studies demonstrate that the impairment of acid hydrolase secretion in SPD platelets, documented here and in earlier (28, 29) , we cannot rule out the possibility that the correction of secretion by ADP may be unrelated to the cause of the impairment. Alternatively, the impaired secretion response could be associated with abnormalities in signal transduction processes, or in the lysosomal granule structure itself, which would render the platelets less sensitive to the secretion stimulus.
Several other findings, however, provide further support for a relationship between the impaired acid hydrolase secretion and the absence of secretable ADP: (a) Secretion was not impaired in SPD platelets with lesser deficiencies of densegranule substances, including patients with a-granule deficiencies as well, suggesting that the impairment might be specifically associated with the virtual absence of dense-granule constituents in the affected patients. (b) Addition of excess ATP, which acts as a specific inhibitor of ADP-mediated responses, to normal platelets produced an impairment of acid hydrolase secretion similar to that in SPD platelets, even in the absence of added ADP. Under these conditions, the most likely target for the inhibitory effects ofATP would be secreted ADP. (c) Both the ATP-induced impairment of secretion in normal platelets and the impairment ofsecretion in SPD platelets were reversed when a higher concentration of thrombin was used, conditions under which thrombin activates platelets independently of secreted (30) or added (28) ADP.
While ADP was able to correct the impaired acid hydrolase secretion in SPD platelets, the platelet sensitivity to these effects of ADP varied markedly among individual patients (Fig.  6) . Correction of this secretion response to normal values required as little as 0.01 uM ADP or as much as 10 ,M ADP in different patients. The reasons for this variation in sensitivity are not clear, but they cannot be related to marked differences in the residual levels of dense-granule ADP present in these patients' platelets (Table I) . These variations could, however, reflect differences in ADP interaction with the platelet membrane, or possibly differences in sensitivity to the primary thrombin stimulus, since some relation between the concentration of ADP required for correction and the extent of secretion induced by thrombin alone, in the absence ofADP, seems evident in Fig. 6 .
The corrective effect of ADP clearly distinguishes the impairment of acid hydrolase secretion seen in SPD platelets from that which occurs in normal platelets after in vivo, but not in vitro, exposure to ASA. Thus, in platelets exposed to ASA in vivo, ADP (10 ,M) increased the extent of secretion, but clearly did not normalize this response (Table VI) , suggesting that the inhibition by ASA could not be completely ascribed to an inhibition of ADP secretion from dense granules. ASA inhibition ofacid hydrolase secretion was associated with, but did not specifically result from, inhibition of cyclooxygenase, since comparable extents of inhibition of TxB2 formation were obtained with both in vivo and in vitro incubation with ASA. Inhibitory effects of ASA, also independent of cyclooxygenase inhibition, have been obtained on rabbit platelet aggregation and dense-granule secretion, but at much higher relative ASA concentrations (31) . Neither the inhibition of lysosomal secretion observed here, nor the inhibition of rabbit platelet function (31), appeared to be due to salicylate. Thus, the mechanism of this inhibitory effect of ASA in vivo remains obscure.
The ability of excess ATP, acting as a specific antagonist of ADP (26) , to partially inhibit acid hydrolase secretion induced by low concentrations of thrombin in normal platelets (Table  IV) suggests that ADP plays a role in the lysosomal secretion response of normal platelets also. Since exogenous ADP did not alter this secretion response in normal platelets, it is reasonable to presume that such effects would most likely occur via ADP secreted from the dense granules. A role for secreted ADP in other platelet responses has been suggested by earlier studies. Thus, e.g., a partial inhibition of dense-granule secretion induced by low concentrations of thrombin, similar to those used in this study, and by A23187 in washed rabbit platelets was observed in the presence of the ADP-removing enzyme system, creatine phosphate-creatine phosphokinase (30) . The activation of phospholipase C by A23187 has also been reported to be totally dependent on secreted ADP and cyclooxygenase products (32) . In addition, correction by ADP of platelet procoagulant defects was demonstrated in one of the early studies of patients with impaired aggregation responses (33) , some of whom were later shown to have SPD (13).
The mechanism by which ADP might mediate acid hydrolase secretion, or whether similar mechanisms govern the effects of ADP on acid hydrolase secretion and on the other platelet responses described above, remains to be defined. The results shown in Table III demonstrate that the effects of ADP on acid hydrolase secretion occur in association with the direct activation of the platelets in suspension, and are not a secondary, "conditioning" effect (23) promoting centrifugation-induced secretion. In addition, the results in Table IV indicate that these effects are dependent on the interaction ofADP with its membrane receptor. Thus, the effects of ADP could reflect simply a synergistic interaction with thrombin or A23187, similar to those described for many other pairs ofagonists (29, 34) . However, it is important to note a fundamental difference between the effects ofADP on acid hydrolase secretion and the synergistic interactions of pairs of agonists described in the latter two references. As shown in earlier studies (35) as well as in the present studies, ADP alone was incapable of inducing acid hydrolase secretion, and thus cannot be considered an agonist for this response. These effects of ADP are therefore not strictly comparable to synergistic interactions between pairs of agonists but may instead represent potentiation of the thrombin-or ionophore-induced lysosomal secretion response by ADP. This potentiation was most evident as an increased sensitivity of the platelets to lower concentrations of the primary stimulus, and was usually not associated with an increased maximal extent of secretion. A similar pattern of potentiation ofthrombin-induced dense granule secretion by epinephrine, under conditions where epinephrine itself does not induce secretion, has been demonstrated by Steen and Holmsen (36) . The present studies indicate that epinephrine, which, like ADP, does not induce acid hydrolase secretion itself, also enhances thrombin-induced lysosomal secretion, and preliminary studies (Holmsen, H., unpublished observations) indicate that the dose response curve for this response is also shifted to the left by epinephrine.
These effects of epinephrine, as well as its ability to restore irreversible aggregation in functionally inhibited platelets (22) , were observed at micromolar levels of this substance. However, our findings that no potentiation of acid hydrolase secretion occurred at nanomolar levels of epinephrine, comparable to the amounts normally present in plasma or secreted from platelets, indicate that epinephrine potentiation of this response may not be as significant physiologically as potentiation by ADP.
